ophthafutur hpmc for multiple purposes during ophthalmic surgery.


Crystal clear view

Endotoxin free

Preloaded syringe

 ophthafutur hpmc packshot


bacterial endotoxins and injectability

bacterial endotoxins issue

The world-wide ambition to reduce the acceptable concentration of bacterial endotoxins is a major challenge in manufacturing, especially for products derived from natural raw materials.

HPMC (Hydroxypropylmethylcellulose) is made from natural cellulose. Microbial impurities are therefore a major concern.

The main goal during ophthalmic surgery is to obtain an unobstructed view through the clear media of the eye. Bubbles contained in any liquid product may considerably obstruct the surgeon’s view. The supply of HPMC having a sufficiently high ­viscosity paired with an easy and simple injectability represents an additional challenge.


GMP environment

advanced filling technology

advanced filling technology

our response: scientifically-based engineering

ophthafutur® hpmc is a dispersive ophthalmic viscosurgical device (OVD). Characterized by good wetting properties, excellent tissue and endothelium protection, efficient volume replacement and quick ­removal.

ophthafutur® viscoelastics are in compliance to the standards of pharmaceutical products and are manufactured according to the relevant  GMP guidelines in a fully controlled clean room environment. The filling is performed under pharmaceutical class A conditions avoiding any product contamination. ­Vacuum technology enables bubble free filling.


ophthafutur usability hpmc

fields of application are:

ophthafutur® hpmc can be used for various purposes. The product can be used either intraocularly or extraocularly. It allows excellent visualization when used during surgery due to the absence of bubbles.

ophthafutur® hpmc can be used to wet the cornea during cataract, ­corneal or retinal procedures. The syringe allows an easy application of the product under a microscope.

The product may also be used to lubricate the surfaces of IOL injectors or IOL cartridges.

The patient should be monitored accordingly after surgery, as ­elevated intraocular pressure may occur.


For additional information please consult directions for use.